Maze Therapeutics Inc. (MAZE)
NASDAQ: MAZEHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 26.25 0.00%
MAZE stock chart
Technical analysisKey statistics
All statistics- Market cap
- $1.46B
- EPS (TTM)
- -$2.48
- Dividend yield
- None
- 52-week range
- 21.95 – 53.65
- Day range
- 25.87 – 26.89
- Volume / Avg
- 823.90K / 564.54K
- Beta
- —
- Shares outstanding
- 55.55M
- Next earnings
- Nov 5, 2026
52-week range
MAZE stock today
On Oct 7, MAZE ended the session at $26.25, shedding $0.18 (0.68%), versus the S&P 500's 0.22% decline. Shares are 51.1% below their 52-week high of $53.65, set on Mar 16, 2026 and 19.6% above the 52-week low of $21.95, near the bottom of the past year's range. MAZE is down 36.6% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 5.8%.
Maze Therapeutics has posted a net loss over the last twelve months (EPS of -$2.48), so its P/E ratio is not meaningful. Maze Therapeutics's next earnings report is expected on Nov 5, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Maze Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- IPO year
- 2025
Earnings
Earnings history- Next report
- Nov 5, 2026
- EPS estimate
- $-0.78
Maze Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| TSHATaysha Gene Therapies Inc. | 4.43 | +0.91% | $1.44B | vs MAZE |
| IMCRImmunocore Holdings plc ADR | 29.41 | -0.47% | $1.51B | vs MAZE |
| INBXInhibrx Biosciences Inc. | 93.36 | -0.05% | $1.37B | vs MAZE |
| COAGHemab Therapeutics Holdings Inc. | 28.70 | +1.16% | $1.34B | vs MAZE |
| REPLReplimune Group Inc. | 13.20 | -0.38% | $1.24B | vs MAZE |
| IMTXImmatics N.V. | 7.45 | -0.67% | $1.13B | vs MAZE |
| VORVor Biopharma Inc. | 18.78 | +2.57% | $1.11B | vs MAZE |
| MGTXMeiraGTx Holdings plc | 10.82 | +2.08% | $1.04B | vs MAZE |
Indexes, lists and sector
Largest Health Care stocks
Maze Therapeutics stock FAQ
What is Maze Therapeutics's stock price today?
MAZE last traded at $26.25 as of Oct 7, 4:00 PM EDT, down 0.68% on the day. Prices are delayed at least 15 minutes.
When is Maze Therapeutics's next earnings date?
Maze Therapeutics is expected to report earnings on Thursday, November 5, 2026. Analysts expect EPS of $-0.78.
What is the MAZE 52-week high?
The 52-week high for MAZE is $53.65 and the 52-week low is $21.95. The stock is currently 51.1% below its high.